Innovate Health
General Business

Meteoric Biopharmaceuticals Opening New Facility in NJ

Biopharmaceutical and biotechnology leader Meteoric Biopharmaceuticals USA, LLC is expanding its global operations to New Jersey with the planned opening of a Morris Plains facility that will act as a distribution warehouse, storing an inventory of enzymes, probiotics, and nutraceuticals.

The facility will create nearly a dozen new jobs and the company plans to add more positions in 2023. Meteoric, which is based in India, plans to undertake additional Research and Development projects in the United States with New Jersey at the center of its North American operations.

“I am so proud to welcome Meteoric Biopharmaceuticals to New Jersey,” said Wesley Mathews, president & CEO of Choose New Jersey. “This expansion adds to the state’s impressive roster of industry leaders in the life sciences sector. As New Jersey continues its storied history of developing lifesaving pharmaceuticals, we are thrilled to continue developing a strong global network of the world’s smartest minds who bring their talents to our great state.”

“Having a physical presence in New Jersey is essential for Meteoric to reach the next level in biopharmaceutical manufacturing,” said Gaurav Kaushik, MD & CEO of Meteoric Biopharmaceuticals. “In addition to its ideal proximity to our target markets, New Jersey has one of the most advanced pharmaceutical ecosystems in the United States. We are thrilled to plant roots here, while continuing to prioritize quality assurance for clients old and new.”

“This expansion brings together two powerhouses in the pharmaceutical industry,” said Tarun Gupta, representative to the New Jersey India Center. “Meteoric Biopharmaceuticals is already a global leader – expanding to New Jersey and gaining access to the state’s exceptional talent pool and pharmaceutical ecosystem will further solidify the company’s position around the world.”

Meteoric Biopharmaceuticals is a first-generation, research driven, integrated, and diversified global biopharmaceuticals leader. Aligning with the New Jersey philosophy of “Innovations through Discovery,” the company services 500 customers across 50 industries in more than 90 countries.

To access more business news, visit NJB News Now.

Related Articles: